The Oncology Institute Announces Second Quarter 2026 Earnings Release Date and Conference Call
Rhea-AI Summary
The Oncology Institute (NASDAQ: TOI) will release its second quarter 2026 financial results on Thursday, August 6, 2026, followed by a conference call at 5:00 p.m. Eastern Time. Investors can access the call via domestic and international dial-in numbers or through a live webcast on the company’s investor relations website. A telephone replay and webcast replay will be available until 11:59 p.m. Eastern Time on August 20, 2026.
Positive
- None.
Negative
- None.
Market reaction after 2Q26 earnings release date: TOI +4.22% in the Jul 27 session
In the Jul 27 session, TOI gained 4.22%, reflecting a moderate positive market reaction. Argus tracked a peak move of +2.5% during that session. Argus tracked a trough of -8.9% from its starting point during tracking. Our momentum scanner triggered 21 alerts that day, indicating elevated trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Conferences,earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 27 | Earnings release date | Neutral | +2.5% | Announced first-quarter 2026 results release date and conference call details |
| Feb 26 | Earnings release date | Neutral | +4.2% | Announced fourth-quarter and full-year 2025 results release date |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Both prior tag-matched earnings-date announcements were followed by positive 24-hour price reactions of 2.46% and 4.2%, despite being scheduling notices.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CERRITOS, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncology care, today announced that the company will release its second quarter 2026 financial results on Thursday, August 6, 2026, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).
The conference call can be accessed live over the phone by dialing 1-833-316-1983 or, for international callers, 1-785-838-9310, and referencing Conference ID: TOI. A replay will be available approximately three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 11162290. The replay will be available until Thursday, August 20, 2026 at 11:59 p.m. (Eastern Time).
Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/.
About The Oncology Institute
Founded in 2007, The Oncology Institute, Inc. (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 2.1 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 400 employed and network clinicians and over 100 clinics and network locations of care across five states and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.
Contacts
Media
The Oncology Institute, Inc.
marketing@theoncologyinstitute.com
Investors
ICR Healthcare
TOI@icrhealthcare.com
